文献速递淋巴瘤

Wnt5a诱导ROR1与HS1形成复合物增强慢性淋巴细胞白血病细胞迁移

Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.
PubMed 文献 · Leukemia · 2017-05-03

研究发现慢性淋巴细胞白血病(CLL)细胞中ROR1与HS1结合,Wnt5a可诱导HS1酪氨酸磷酸化、招募ARHGEF1、激活RhoA并增强趋化因子定向迁移,该效应可被抗ROR1单抗cirmtuzumab抑制;ROR1的PRD结构域第841位脯氨酸是HS1招募和细胞迁移所必需。

要点

  • Wnt5a诱导CLL细胞中ROR1与HS1结合并促进HS1酪氨酸磷酸化。
  • Wnt5a通过ROR1增强趋化因子定向迁移,可被cirmtuzumab抑制。
  • ROR1 PRD第841位脯氨酸是Wnt5a诱导HS1磷酸化和细胞迁移的关键位点。

核心结论

  • HS1在ROR1依赖的Wnt5a增强趋化因子定向白血病细胞迁移中起重要作用。

研究设计与样本

  • 研究在新鲜分离的CLL细胞或与外源性Wnt5a培养的CLL细胞中进行,并构建ROR1截短体及脯氨酸至丙氨酸点突变体。

主要发现

  • 新鲜分离的CLL细胞或与外源性Wnt5a培养的CLL细胞中ROR1与HS1结合。
  • Wnt5a诱导HS1酪氨酸磷酸化、招募ARHGEF1、激活RhoA并增强趋化因子定向迁移,这些效应可被cirmtuzumab抑制。
  • ROR1的胞外富半胱氨酸结构域或kringle结构域是Wnt5a诱导HS1磷酸化所必需。
  • ROR1胞质区尤其是富脯氨酸结构域(PRD)是其与HS1结合及Wnt5a诱导F-actin聚合所必需。
  • ROR1P(841)A突变体相比野生型ROR1或其他ROR1P→A突变体,招募HS1和ARHGEF1的能力受损;表达ROR1P(841)A的细胞中Wnt5a不能诱导HS1磷酸化或激活ARHGEF1,也不能增强CLL细胞运动。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ROR1 (receptor tyrosine kinase-like orphan receptor 1) is a conserved, oncoembryonic surface antigen expressed in chronic lymphocytic leukemia (CLL). We found that ROR1 associates with hematopoietic-lineage-cell-specific protein 1 (HS1) in freshly isolated CLL cells or in CLL cells cultured with exogenous Wnt5a. Wnt5a also induced HS1 tyrosine phosphorylation, recruitment of ARHGEF1, activation of RhoA and enhanced chemokine-directed migration; such effects could be inhibited by cirmtuzumab, a humanized anti-ROR1 mAb. We generated truncated forms of ROR1 and found its extracellular cysteine-rich domain or kringle domain was necessary for Wnt5a-induced HS1 phosphorylation. Moreover, the cytoplamic, and more specifically the proline-rich domain (PRD), of ROR1 was required for it to associate with HS1 and allow for F-actin polymerization in response to Wnt5a. Accordingly, we introduced single amino acid substitutions of proline (P) to alanine (A) in the ROR1 PRD at positions 784, 808, 826, 841 or 850 in potential SH3-binding motifs. In contrast to wild-type ROR1, or other ROR1P→︀A mutants, ROR1P(841)A had impaired capacity to recruit HS1 and ARHGEF1 to ROR1 in response to Wnt5a. Moreover, Wnt5a could not induce cells expressing ROR1P(841)A to phosphorylate HS1 or activate ARHGEF1, and was unable to enhance CLL-cell motility. Collectively, these studies indicate HS1 plays an important role in ROR1-dependent Wnt5a-enhanced chemokine-directed leukemia-cell migration.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Hasan MK, Yu J, Chen L, et al. Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells. Leukemia. 2017. PMID: 28465529. doi:10.1038/leu.2017.133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。